Some say that Cologuard can find 40-50% of precancerous lesions.
Seems like colonoscopy is profitable and gets advertised very well. But molecular testing is pretty great and will keep improving no doubt.
Here is a recent super serious review
Participation goals for colorectal cancer (CRC) screening in the USA have not been met. Non-invasive screening strategies may improve CRC screening participation. We highlight recent literature on stool-based screening performance and expectations ...
www.ncbi.nlm.nih.gov
also
An at-home test for colon cancer is as reliable as the traditional screening, health experts say, and more agreeable.
www.nytimes.com